Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.11 -0.10 (-2.38%)
As of 03:47 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.12 billion
P/E Ratio
29.36
Consensus Rating
Strong Buy
Volume
121,614 shares
Average Volume
119,366 shares
Today's Range
$3.95
$4.20
NexGen Energy stock logo

2. NexGen Energy NYSE:NXE

$4.10 -0.09 (-2.03%)
Closing price 03:59 PM Eastern
Extended Trading
$4.17 +0.08 (+1.83%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$2.33 billion
P/E Ratio
27.30
Consensus Rating
Strong Buy
Volume
12.99 million shares
Average Volume
6.69 million shares
Today's Range
$3.91
$4.42
OnKure Therapeutics stock logo

3. OnKure Therapeutics NASDAQ:OKUR

$3.09 -0.04 (-1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$3.08 -0.01 (-0.49%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$41.52 million
P/E Ratio
-0.25
Consensus Rating
Buy
Consensus Price Target
$32.33 (+946.4% Upside)
Volume
211,537 shares
Average Volume
83,815 shares
Achieve Life Sciences stock logo

4. Achieve Life Sciences NASDAQ:ACHV

$2.22 +0.04 (+1.83%)
Closing price 04:00 PM Eastern
Extended Trading
$2.22 +0.00 (+0.23%)
As of 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$77.00 million
P/E Ratio
-1.96
Consensus Rating
Buy
Consensus Price Target
$15.75 (+609.5% Upside)
Volume
322,921 shares
Average Volume
178,196 shares
Stardust Power stock logo

5. Stardust Power NASDAQ:SDST

$0.51 +0.00 (+0.85%)
Closing price 04:00 PM Eastern
Extended Trading
$0.49 -0.02 (-4.31%)
As of 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$29.53 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+902.5% Upside)
Volume
248,390 shares
Average Volume
359,629 shares
Today's Range
$0.42
$0.52
OS Therapies stock logo

6. OS Therapies NYSE:OSTX

$1.43 +0.03 (+2.14%)
Closing price 04:00 PM Eastern
Extended Trading
$1.39 -0.04 (-2.66%)
As of 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$30.98 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+1,158.7% Upside)
Volume
131,864 shares
Average Volume
505,340 shares
Today's Range
$1.36
$1.46
Remove Ads
Denison Mines stock logo

7. Denison Mines NYSEAMERICAN:DNN

$1.18 -0.01 (-0.84%)
Closing price 04:10 PM Eastern
Extended Trading
$1.18 0.00 (0.00%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.06 billion
P/E Ratio
-118.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+154.2% Upside)
Volume
106.86 million shares
Average Volume
27.24 million shares
Solid Biosciences stock logo

8. Solid Biosciences NASDAQ:SLDB

$2.94 -0.18 (-5.77%)
Closing price 04:00 PM Eastern
Extended Trading
$3.01 +0.07 (+2.38%)
As of 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$227.83 million
P/E Ratio
-0.97
Consensus Rating
Buy
Consensus Price Target
$15.67 (+432.9% Upside)
Volume
1.15 million shares
Average Volume
867,420 shares
enCore Energy stock logo

9. enCore Energy NASDAQ:EU

$1.19 +0.03 (+2.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.18 -0.01 (-1.26%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore Energy

Market Capitalization
$221.80 million
P/E Ratio
-4.25
Consensus Rating
Buy
Consensus Price Target
$4.38 (+267.6% Upside)
Volume
2.60 million shares
Average Volume
1.45 million shares
Uranium Energy stock logo

10. Uranium Energy NYSEAMERICAN:UEC

$4.10 -0.12 (-2.84%)
Closing price 04:10 PM Eastern
Extended Trading
$4.14 +0.04 (+0.85%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. More about Uranium Energy

Market Capitalization
$1.73 billion
P/E Ratio
-34.17
Consensus Rating
Buy
Consensus Price Target
$10.60 (+158.5% Upside)
Volume
15.40 million shares
Average Volume
7.60 million shares
Bioceres Crop Solutions stock logo

11. Bioceres Crop Solutions NASDAQ:BIOX

$3.97 -0.16 (-3.87%)
Closing price 04:00 PM Eastern
Extended Trading
$3.98 +0.00 (+0.13%)
As of 05:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$248.96 million
P/E Ratio
198.60
Consensus Rating
Buy
Consensus Price Target
$9.88 (+148.7% Upside)
Volume
198,506 shares
Average Volume
163,080 shares
Remove Ads
GeoVax Labs stock logo

12. GeoVax Labs NASDAQ:GOVX

$0.95 -0.07 (-6.66%)
As of 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$8.98 million
P/E Ratio
-0.17
Consensus Rating
Buy
Consensus Price Target
$14.20 (+1,391.4% Upside)
Volume
345,918 shares
Average Volume
603,179 shares
Reviva Pharmaceuticals stock logo

13. Reviva Pharmaceuticals NASDAQ:RVPH

$0.60 +0.07 (+13.21%)
Closing price 04:00 PM Eastern
Extended Trading
$0.59 -0.01 (-2.00%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$20.07 million
P/E Ratio
-0.54
Consensus Rating
Buy
Consensus Price Target
$10.00 (+1,566.7% Upside)
Volume
862,384 shares
Average Volume
1.10 million shares
Cardiol Therapeutics stock logo

14. Cardiol Therapeutics NASDAQ:CRDL

$0.85 +0.04 (+4.94%)
Closing price 04:00 PM Eastern
Extended Trading
$0.90 +0.05 (+6.00%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$70.22 million
P/E Ratio
-2.18
Consensus Rating
Buy
Consensus Price Target
$8.40 (+888.2% Upside)
Volume
453,254 shares
Average Volume
385,168 shares
Quince Therapeutics stock logo

15. Quince Therapeutics NASDAQ:QNCX

$1.22 -0.02 (-1.61%)
Closing price 04:00 PM Eastern
Extended Trading
$1.21 -0.01 (-0.82%)
As of 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$53.68 million
P/E Ratio
-0.98
Consensus Rating
Buy
Consensus Price Target
$8.00 (+555.7% Upside)
Volume
163,029 shares
Average Volume
245,264 shares
Astria Therapeutics stock logo

16. Astria Therapeutics NASDAQ:ATXS

$4.50 -0.16 (-3.43%)
Closing price 04:00 PM Eastern
Extended Trading
$4.62 +0.12 (+2.69%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Astria Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. More about Astria Therapeutics

Market Capitalization
$253.95 million
P/E Ratio
-2.15
Consensus Rating
Buy
Consensus Price Target
$26.60 (+491.1% Upside)
Volume
611,701 shares
Average Volume
392,765 shares
Remove Ads
Immunic stock logo

17. Immunic NASDAQ:IMUX

$0.94 -0.05 (-5.21%)
Closing price 04:00 PM Eastern
Extended Trading
$0.95 +0.01 (+0.72%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$85.03 million
P/E Ratio
-0.77
Consensus Rating
Buy
Consensus Price Target
$13.20 (+1,299.5% Upside)
Volume
769,046 shares
Average Volume
614,790 shares
Full House Resorts stock logo

18. Full House Resorts NASDAQ:FLL

$3.16 -0.17 (-5.11%)
Closing price 04:00 PM Eastern
Extended Trading
$3.16 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$113.37 million
P/E Ratio
-2.68
Consensus Rating
Buy
Consensus Price Target
$6.33 (+100.4% Upside)
Volume
285,952 shares
Average Volume
128,525 shares
Mereo BioPharma Group stock logo

19. Mereo BioPharma Group NASDAQ:MREO

$1.83 -0.16 (-8.04%)
Closing price 04:00 PM Eastern
Extended Trading
$1.84 +0.01 (+0.55%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$283.92 million
P/E Ratio
-30.50
Consensus Rating
Buy
Consensus Price Target
$7.71 (+321.5% Upside)
Volume
2.78 million shares
Average Volume
1.03 million shares
Nkarta stock logo

20. Nkarta NASDAQ:NKTX

$1.56 -0.07 (-4.29%)
Closing price 04:00 PM Eastern
Extended Trading
$1.54 -0.02 (-0.96%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$110.69 million
P/E Ratio
-0.83
Consensus Rating
Buy
Consensus Price Target
$14.86 (+852.4% Upside)
Volume
1.20 million shares
Average Volume
1.10 million shares
Rezolve AI stock logo

21. Rezolve AI NASDAQ:RZLV

$1.28 -0.01 (-0.78%)
Closing price 04:00 PM Eastern
Extended Trading
$1.28 +0.00 (+0.39%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$220.39 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+368.8% Upside)
Volume
2.39 million shares
Average Volume
5.17 million shares
Today's Range
$1.17
$1.38
Electrovaya stock logo

22. Electrovaya NASDAQ:ELVA

$2.39 +0.01 (+0.42%)
Closing price 03:59 PM Eastern
Extended Trading
$2.38 -0.02 (-0.63%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about Electrovaya

Market Capitalization
$95.86 million
P/E Ratio
-59.75
Consensus Rating
Buy
Consensus Price Target
$6.10 (+155.2% Upside)
Volume
19,470 shares
Average Volume
51,084 shares
PMV Pharmaceuticals stock logo

23. PMV Pharmaceuticals NASDAQ:PMVP

$0.96 -0.04 (-4.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.96 0.00 (-0.42%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV Pharmaceuticals

Market Capitalization
$49.86 million
P/E Ratio
-0.96
Consensus Rating
Buy
Consensus Price Target
$5.50 (+472.9% Upside)
Volume
129,681 shares
Average Volume
271,770 shares
Lucid Diagnostics stock logo

24. Lucid Diagnostics NASDAQ:LUCD

$1.55 +0.11 (+7.64%)
Closing price 04:00 PM Eastern
Extended Trading
$1.55 0.00 (0.00%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$140.67 million
P/E Ratio
-1.36
Consensus Rating
Buy
Consensus Price Target
$3.40 (+119.4% Upside)
Volume
1.88 million shares
Average Volume
377,990 shares
Clene stock logo

25. Clene NASDAQ:CLNN

$2.68 -0.01 (-0.19%)
Closing price 03:56 PM Eastern
Extended Trading
$2.82 +0.13 (+4.84%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clene Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. More about Clene

Market Capitalization
$23.08 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$55.25 (+1,957.7% Upside)
Volume
24,593 shares
Average Volume
78,753 shares